# Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery

> **NCT07343596** · NA · RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 20 (estimated)

## Conditions studied

- Oral Cavity Cancer

## Interventions

- **BIOLOGICAL:** Pembrolizumab
- **DEVICE:** Patient-Specific Culture Vessel

## Key facts

- **NCT ID:** NCT07343596
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07343596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07343596, "Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07343596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*